160 HEALTH (02656) saw its shares surge more than 10% during the trading session, reaching a high of HKD 155.60 and setting a new record high since its listing. As of the time of writing, the stock was up 7.40%, trading at HKD 150.90, with a turnover of HKD 96.602 million.

The company issued a profit alert, forecasting an adjusted net profit (a non-IFRS measure) between RMB 3 million and RMB 5 million for the fiscal year ending December 31, 2025. This compares to an adjusted net loss of RMB 31.5 million in the same period last year. This marks the group's first full-year profit on an adjusted basis. The improvement is primarily attributed to a year-on-year increase in revenue, which led to a slight growth in gross profit, coupled with a significant reduction in total operating expenses for the year due to refined management and continuously enhanced operational efficiency.